When a scandal blew up early this year over the questionable purchase of shares by India's largest mutual fund UTI, the country's financial markets and its government had expected redemption pressure so substantial they feared it could threaten the company's existence. The inextricable link between the fate of UTI and that of India's mutual fund industry and stock markets would mean the knock-on effect would have been disastrous for the country. Over 20 million investors have bought its units, and it manages assets worth Rs575 billion (US$12.23 billion) – about two-thirds of all assets managed by the Indian mutual fund industry. To avoid this situation, UTI itself came up with a special plan for the redemption and repurchase of units from small investors beginning August 1. As it transpired, however, few investors showed interest. Between August 1 and 16 the company received repurchase requests for only 82 million units from the 63,523 investors of the US64 scheme (the largest of the company's 87 schemes, which was at the centre of the controversy). This is approximately the same number of redemption requests it gets for US64 under normal circumstances.
September 01, 2001